{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:23:06Z","timestamp":1778923386511,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.autrev.2009.11.013","type":"journal-article","created":{"date-parts":[[2009,11,20]],"date-time":"2009-11-20T16:01:34Z","timestamp":1258732894000},"page":"A299-A304","source":"Crossref","is-referenced-by-count":151,"title":["The geoepidemiology of the antiphospholipid antibody syndrome"],"prefix":"10.1016","volume":"9","author":[{"given":"Martina","family":"Biggioggero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pier Luigi","family":"Meroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2009.11.013_bib1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.autrev.2009.11.013_bib2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.autrev.2006.06.008","article-title":"New subsets of the antiphospholipid syndrome in 2006: \u201cPRE-APS\u201d (probable APS) and microangiopathic antiphospholipid syndromes (\u201cMAPS\u201d)","volume":"6","author":"Asherson","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2009.11.013_bib3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11926-001-0030-5","article-title":"The epidemiology of the antiphospholipid syndrome: who is at risk?","volume":"3","author":"Finazzi","year":"2001","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2009.11.013_bib4","first-page":"1560","article-title":"Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals","volume":"31","author":"Giron-Gonzalez","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2009.11.013_bib5","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.autrev.2007.11.011","article-title":"Lessons from the \u201cEuro-phospholipid\u201d project","volume":"7","author":"Cervera","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2009.11.013_bib6","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1111\/j.1538-7836.2007.02763.x","article-title":"Anti-beta 2 glycoprotein I antibodies and the risk of myocardial infarction in young premenopausal women","volume":"5","author":"Meroni","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.autrev.2009.11.013_bib7","first-page":"13","article-title":"Epidemiology of the antiphospholipid syndrome","volume":"vol. 10","author":"Mchrani","year":"2009"},{"key":"10.1016\/j.autrev.2009.11.013_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1212\/WNL.48.1.91","article-title":"Anticardiolipin antibodies and the risk of recurrent thrombo-occlusive events and death","volume":"48","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2009.11.013_bib9","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood-2002-02-0441","article-title":"Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature","volume":"101","author":"Galli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2009.11.013_bib10","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1182\/blood-2002-11-3334","article-title":"Antibeta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome","volume":"102","author":"Galli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2009.11.013_bib11","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1136\/ard.2008.093179","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients","volume":"68","author":"Cervera","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2009.11.013_bib12","doi-asserted-by":"crossref","first-page":"997","DOI":"10.7326\/0003-4819-117-12-997","article-title":"Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis","volume":"117","author":"Ginsburg","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2009.11.013_bib13","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9343(98)00060-6","article-title":"Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy","volume":"104","author":"Schulman","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2009.11.013_bib14","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/j.1538-7836.2005.01394.x","article-title":"The presence of IgG antibodies against anti-B2-glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulant","volume":"3","author":"Zoghlami-Rintelen","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.autrev.2009.11.013_bib15","first-page":"2214","article-title":"Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis","volume":"33","author":"Opatrny","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2009.11.013_bib16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/MBC.0b013e328304dffc","article-title":"Thrombophilic dimension of recurrent fetal loss in Indian patients","volume":"19","author":"Vora","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.autrev.2009.11.013_bib17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0029-7844(03)00477-0","article-title":"Anticardiolipin and anti-B2-glycoprotein I antibodies in preeclampsia","volume":"102","author":"Lee","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.autrev.2009.11.013_bib18","first-page":"9","article-title":"Elevated antiphospholipid antibody titers and adverse pregnancy outcomes: analysis of a population-based hospital dataset","volume":"16","author":"Nodler","year":"2009","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.autrev.2009.11.013_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0301-2115(97)02736-X","article-title":"Anti-beta 2 glycoprotein I antibodies in general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome. Anti-beta2 glycoprotein I antibodies are associated with some obstetrical complications, mainly preeclampsia\u2013eclampsia","volume":"73","author":"Faden","year":"1997","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.autrev.2009.11.013_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0002-9343(94)90108-2","article-title":"Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients","volume":"96","author":"Vianna","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2009.11.013_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/jaut.2000.0402","article-title":"Long-term prognosis of antiphospholipid syndrome in patients with systemic lupus erythematosus","volume":"15","author":"Alarc\u00f3n-Segovia","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2009.11.013_bib22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.rdc.2005.01.011","article-title":"Antiphospholipid syndrome in systemic lupus erythematosus: is the whole greater than the sum of its parts?","volume":"31","author":"Laskin","year":"2005","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2009.11.013_bib23","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3899\/jrheum.081194","article-title":"Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus","volume":"36","author":"Danowski","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2009.11.013_bib24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0002-9343(99)00053-4","article-title":"Serum antibeta2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients","volume":"106","author":"Gomez-Pacheco","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2009.11.013_bib25","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/art.20120","article-title":"The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of Systemic Lupus Erythematosus","volume":"50","author":"McClain","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2009.11.013_bib26","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/096120339700600510","article-title":"Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus\u2014a meta-analysis","volume":"6","author":"Wahl","year":"1997","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2009.11.013_bib27","first-page":"2531","article-title":"Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus","volume":"29","author":"Somers","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2009.11.013_bib28","first-page":"1775","article-title":"Anti-B2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus","volume":"33","author":"Danowski","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2009.11.013_bib29","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.AOG.0000194205.95870.86","article-title":"Early risk factors for pregnancy loss in lupus","volume":"107","author":"Clowse","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.autrev.2009.11.013_bib30","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.exger.2004.08.003","article-title":"Anti-beta 2 glycoprotein I antibodies in centenarians","volume":"39","author":"Meroni","year":"2004","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.autrev.2009.11.013_bib31","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.autrev.2007.10.001","article-title":"Antiphospholipid antibodies, antiphospholipid syndrome and infection","volume":"7","author":"S\u00e8ne","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2009.11.013_bib32","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/ard.2007.083873","article-title":"Antiphospholipid syndrome dilemmas still to be solved: 2008 status","volume":"67","author":"Shoenfeld","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2009.11.013_bib33","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.berh.2008.09.008","article-title":"Autoimmune diseases induced by TNF-targeted therapies","volume":"22","author":"Ramos-Casals","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2009.11.013_bib34","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.autrev.2008.11.003","article-title":"Treatment of rheumatoid arthritis with anti-TNF-alpha agents: a reappraisal","volume":"8","author":"Caporali","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2009.11.013_bib35","article-title":"Antiphospholipid antibodies and malignancies","author":"Tincani","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2009.11.013_bib36","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0188-4409(01)00359-9","article-title":"Anti-cardiolipin, anticardiolipin plus bovine, or human b2glycoprotein-I and anti-human b2glycoprotein-I antibodies in a healthy infant population","volume":"33","author":"Cabiedes","year":"2002","journal-title":"Arch Med Res"},{"key":"10.1016\/j.autrev.2009.11.013_bib37","doi-asserted-by":"crossref","first-page":"e1100","DOI":"10.1542\/peds.2008-1209","article-title":"Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry","volume":"122","author":"Av\u010din","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.autrev.2009.11.013_bib38","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1136\/ard.2005.038448","article-title":"Ethnic and geographical variation in antiphospholipid (Hughes) syndrome","volume":"64","author":"Uthman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2009.11.013_bib39","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1568-9972(03)00068-5","article-title":"HLA class II alleles and genetic predisposition to the antiphospholipid syndrome","volume":"2","author":"Sebastiani","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2009.11.013_bib40","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1002\/art.24701","article-title":"Association of STAT4 and BLK, but not BANK1 or IRF5, with primary antiphospholipid syndrome","volume":"60","author":"Yin","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2009.11.013_bib41","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaut.2009.05.002","article-title":"Management of antiphospholipid syndrome","volume":"33","author":"Tuthill","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2009.11.013_bib42","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jaut.2009.02.008","article-title":"Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the \"CAPS Registry\"","volume":"32","author":"Cervera","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2009.11.013_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2008.10.003","article-title":"The physiopathology of the catastrophic antiphospholipid (Asherson's) syndrome: compelling evidence","volume":"32","author":"Ortega-Hernandez","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2009.11.013_bib44","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/art.23311","article-title":"Neuropsychological development of children born to patients with antiphospholipid syndrome","volume":"59","author":"Nacinovich","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2009.11.013_bib45","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1002\/art.24708","article-title":"The effects of phosphatidylserine-dependent antiprothrombin antibody on thrombin generation","volume":"60","author":"Sakai","year":"2009","journal-title":"Arthriti Rheum"},{"key":"10.1016\/j.autrev.2009.11.013_bib46","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.autrev.2009.03.007","article-title":"Clinical significance of antiphosphatidylethanolamine antibodies in the so-called \"seronegative antiphospholipid syndrome\"","volume":"9","author":"Sanmarco","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2009.11.013_bib47","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/art.24262","article-title":"beta2-glycoprotein i is a cofactor for tissue plasminogen activator-mediated plasminogen activation","volume":"60","author":"Bu","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2009.11.013_bib48","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.autrev.2008.08.004","article-title":"Cardiovascular involvement in systemic autoimmune diseases","volume":"8","author":"Sitia","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2009.11.013_bib49","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/art.23387","article-title":"Beta2-glycoprotein I protects thrombin from inhibition by heparin cofactor II: potentiation of this effect in the presence of anti-beta2-glycoprotein I autoantibodies","volume":"58","author":"Rahgozar","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2009.11.013_bib50","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaut.2007.11.014","article-title":"Pathogenesis of the antiphospholipid syndrome: an additional example of the mosaic of autoimmunity","volume":"30","author":"Meroni","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2009.11.013_bib51","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2007.11.011","article-title":"Autoantibody explosion in antiphospholipid syndrome","volume":"30","author":"Shoenfeld","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2009.11.013_bib52","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1002\/art.22802","article-title":"Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts","volume":"56","author":"Sorice","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2009.11.013_bib53","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/art.22522","article-title":"Some antiphospholipid antibodies recognize conformational epitopes shared by beta2-glycoprotein I and the homologous catalytic domains of several serine proteases","volume":"56","author":"Lin","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2009.11.013_bib54","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/art.22367","article-title":"Beta2-glycoprotein I binds thrombin via exosite I and exosite II: anti-beta2-glycoprotein I antibodies potentiate the inhibitory effect of beta2-glycoprotein I on thrombin-mediated factor XIa generation","volume":"56","author":"Rahgozar","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2009.11.013_bib55","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1002\/art.21968","article-title":"Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V","volume":"54","author":"Shi","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2009.11.013_bib56","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/art.21549","article-title":"Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappaB\/Rel proteins via the p38 mitogen-activated protein kinase pathways, and of the MEK-1\/ERK pathway","volume":"54","author":"Lopez-Pedrerra","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2009.11.013_bib57","first-page":"622","article-title":"Antiphospholipid antibody profiles and their clinical associations in Chinese patients with systemic lupus erythematosus","volume":"32","author":"Mok","year":"2005","journal-title":"J Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997209001918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997209001918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T03:53:53Z","timestamp":1544846033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997209001918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S1568997209001918"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2009.11.013","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}